From post

The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it.

, и . Clinical pharmacology and therapeutics, 91 (3): 550-4 (марта 2012)Dades censurades; RCT; Regulació; Imputació múltiple; LOCF.
DOI: 10.1038/clpt.2011.340

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it., и . Clinical pharmacology and therapeutics, 91 (3): 550-4 (марта 2012)Dades censurades; RCT; Regulació; Imputació múltiple; LOCF.